209 related articles for article (PubMed ID: 3207319)
1. [Serum CA 125 and TPA determination in malignant neoplasms of the uterus].
Gadducci A; Facchini V; Bartolini T; Fioretti P
Ann Ostet Ginecol Med Perinat; 1988; 109(3):151-5. PubMed ID: 3207319
[No Abstract] [Full Text] [Related]
2. Evaluation of carcinoembryonic antigen, tissue polypeptide antigen, and squamous cell carcinoma antigen in the detection of cervical cancers.
Lam CP; Yuan CC; Jeng FS; Tsai LC; Yeh SH; Ng HT
Zhonghua Yi Xue Za Zhi (Taipei); 1992 Jul; 50(1):7-13. PubMed ID: 1326391
[TBL] [Abstract][Full Text] [Related]
3. Ca-125 levels in the conditioned media of the gynecological tumor cell lines.
Ishiwata I; Ishiwata C
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jan; 37(1):147-8. PubMed ID: 3855943
[No Abstract] [Full Text] [Related]
4. [Tumor markers in uterine cancers].
Fukasawa I; Kousaka N; Kun Z; Inaba N
Gan To Kagaku Ryoho; 2002 Feb; 29(2):333-40. PubMed ID: 11865645
[TBL] [Abstract][Full Text] [Related]
5. [Clinical significance of tissue polypeptide antigen (TPA) and carbohydrate antigen 12-5 (CA 12-5) in the sera from patients with various gynecologic tumors].
Tohya T; Inoue S; Tanaka N; Fujisaki S; Maeyama M
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Dec; 37(12):2872-5. PubMed ID: 3910744
[No Abstract] [Full Text] [Related]
6. Immuno-histological localization of tissue polypeptide antigen (TPA) in gynecological malignancies.
Ikarashi T; Takeuchi S; Sudo N; Ueda M; Furuya M
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Oct; 37(10):2117-20. PubMed ID: 3908587
[TBL] [Abstract][Full Text] [Related]
7. [Immunomorphological identification of an antigen associated with squamous cell carcinoma of the cervix uteri].
Ievleva ES; Ermoshina NV; Ageenko AI
Eksp Onkol; 1988; 10(5):33-5. PubMed ID: 3061778
[TBL] [Abstract][Full Text] [Related]
8. Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix.
Juang CM; Wang PH; Yen MS; Lai CR; Ng HT; Yuan CC
Gynecol Oncol; 2000 Jan; 76(1):103-6. PubMed ID: 10620449
[TBL] [Abstract][Full Text] [Related]
9. [Clinical usefulness of serum TPA, IAP and CEA levels in gynecological cancer].
Saitoh S; Nakanishi A; Noda T; Ando Y; Kamamoto Y; Moriyama I; Ichijo M
Nihon Gan Chiryo Gakkai Shi; 1984 Aug; 19(7):1496-504. PubMed ID: 6520506
[No Abstract] [Full Text] [Related]
10. [Tumor-associated markers in malignant lung neoplasms].
Piancino G; Racca P; Rayneri W; Piantino P; Cerchier A; Pecchio F
Minerva Med; 1986 Jan; 77(1-2):19-25. PubMed ID: 3945411
[TBL] [Abstract][Full Text] [Related]
11. [The clinical significance of CA125 in patients with gynecological tumors--a comparative study on CA125 and other tumor markers].
Suzumori K; Yasui Y; Asai H; Hisaoka T; Mizuno K; Yagami Y
Gan No Rinsho; 1985 May; 31(5):544-8. PubMed ID: 3860666
[TBL] [Abstract][Full Text] [Related]
12. Comparison between squamous cell carcinoma-associated antigen and CA-125 in patients with carcinoma of the cervix.
Lehtovirta P; Viinikka L; Ylikorkala O
Gynecol Oncol; 1990 May; 37(2):276-8. PubMed ID: 2344974
[TBL] [Abstract][Full Text] [Related]
13. [Immunomorphological studies of the antigen associated with squamous cell cancer of the human cervix uteri].
Ievleva ES; Marshutina NV; Ageenko AN; Khmel'nitskaia NG
Biull Eksp Biol Med; 1992 Mar; 113(3):304-6. PubMed ID: 1421235
[TBL] [Abstract][Full Text] [Related]
14. [Significance of the the tumor markers, Ca-125 and tumor-associated trypsin inhibitor in patients with carcinoma of the cervix and uterus].
Ilić RS; Mihailović D
Srp Arh Celok Lek; 1992; 120(3-4):97-9. PubMed ID: 1465666
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of the levels of CA125, CA19-9, and CEA in the cervical mucus helps a diagnosis of cervical adenocarcinomas].
Fujii S; Konishi I; Nanbu Y; Sagawa N; Nonogaki H; Mori T
Nihon Sanka Fujinka Gakkai Zasshi; 1987 Dec; 39(12):2193-4. PubMed ID: 3480920
[No Abstract] [Full Text] [Related]
16. [Studies on CA 125, CA 19-9, TPA and IAP as tumor markers in patients with ovarian cancer].
Negishi Y; Furuno K; Sano Y; Hirata T; Utsunomiya A; Nakajima H; Okabe K; Shimizu K; Akiya K; Fujiwara Y
Gan No Rinsho; 1985 May; 31(6 Suppl):655-63. PubMed ID: 2993692
[TBL] [Abstract][Full Text] [Related]
17. The prognostic value of TPA and SCC in squamous cell carcinoma of the cervix.
Ngan HY; Cheng GT; Yeung WS; Wong LC; Ma HK
Gynecol Oncol; 1994 Jan; 52(1):63-8. PubMed ID: 8307503
[TBL] [Abstract][Full Text] [Related]
18. [Tumor markers in the diagnosis of pancreatic carcinoma].
Lemma F; Bombardieri T; Salibra M; Trovato P; De Pasquale MC; Faraone V; Punturiero R; Di Mauro S
Minerva Med; 1989 Jul; 80(7):645-9. PubMed ID: 2779818
[No Abstract] [Full Text] [Related]
19. [A study on tumor marker of tissue-polypeptide-antigen (TPA) in gynecologic malignancies].
Nakajima H; Hirata T; Norisugi T; Furuno K; Ikehata N; Utsunomiya A; Kobayashi K; Negishi Y; Akiya K
Nihon Sanka Fujinka Gakkai Zasshi; 1984 Oct; 36(10):1877-83. PubMed ID: 6094688
[TBL] [Abstract][Full Text] [Related]
20. [Tissue polypeptide antigen in gynecological cancer].
Saitoh S; Nakanishi A; Noda T; Yoh S; Ando Y; Moriyama I; Ichijo M
Gan No Rinsho; 1985 Jan; 31(1):65-72. PubMed ID: 3981803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
